Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lamzede 10 mg powder for solution for infusion {equilateral_black_triangle}

Active Ingredient:
velmanase alfa
Company:  
Chiesi Limited See contact details
ATC code: 
A16AB15
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Lamzede® (Velmanase Alfa) IMPORTANT INFORMATION on minimising the risk of hypersensitivity reactions and medication errors in home settings

{healthcare_pro_orange} For Healthcare Professionals
Information for Healthcare Professionals Version No: 0.3 Date: March 2023
{pdf_link}

Lamzede® (Velmanase Alfa) IMPORTANT INFORMATION on minimising the risk of hypersensitivity reactions and medication errors during home infusion. Infusion diary booklet

{healthcare_pro_orange} For Healthcare Professionals
March 2023 This diary is designed to assist with the administration of velmanase alfa. The diary should be kept as a record of when velmanase alfa is administered.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Chiesi Limited
Company image
Address
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG
Telephone
+44 (0) 161 488 5555
Telephone
0800 009 2329
Medical Information e-mail
[email protected]
WWW
http://www.chiesi.uk.com
Product Quality Complaints
[email protected]
Stock Availability
[email protected]
Stock Availability
www.chiesi.uk.com/supply-of-chiesi-products
Drug Safety e-mail
[email protected]
Medical Information Direct Line
+44 (0)1748 827 271
Medical Information Website
https://www.chiesimedical.co.uk